Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAFCILLIN vs NAGLAZYME: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NAFCILLIN vs NAGLAZYME: Safety Overview

Metric NAFCILLIN NAGLAZYME
Total FAERS Reports 215 414
Deaths Reported 18 18
Death Rate 8.4% 4.3%
Hospitalizations 98 88
Average Patient Age 50.7 yrs 12.2 yrs
% Female Patients 50.5% N/A
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Eugia US LLC N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued N/A